Cerulean Pharma reported $2.83M in Trade Creditors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Adamis Pharmaceuticals ADMP:US 4.52M 374.74K
Agile Therapeutics AGRX:US 12.04M 2.5M
Arrowhead Research ARWR:US $ 5.89M 4.71M
Bayer BAYN:GR 6.1B 250M
Biocept BIOC:US $ 8.08M 0.83M
Brainstorm Cell Therapeutics BCLI:US $ 5.29M 722K
Cerulean Pharma CERU:US $ 2.83M 727.79K
Macrogenics MGNX:US $ 2.61M 1.12M
Nektar Therapeutics NKTR:US $ 12.35M 0.27M
Perrigo Ordinary Shares PRGO:US $ 490.4M 10.8M
Seattle Genetics SGEN:US $ 128.87M 41.64M
YTE INCY:US $ 194.77M 42.22M